126 related articles for article (PubMed ID: 3477455)
1. Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.
Lena N; Imbert AM; Favre R; Cano JP; Carcassonne Y
Eur J Cancer Clin Oncol; 1987 May; 23(5):481-5. PubMed ID: 3477455
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
Erttmann R; Bielack S; Landbeck G
Cancer Chemother Pharmacol; 1985; 15(2):101-4. PubMed ID: 3874719
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.
Bore P; Lena N; Imbert AM; Favre R; Cano JP; Meyer G; Carcassonne Y
Cancer Chemother Pharmacol; 1986; 17(2):171-6. PubMed ID: 3719898
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after high-dose (33.6 g/m2) methotrexate therapy.
Slørdal L; Kolmannskog S; Prytz PS; Moe PJ; Aarbakke J
Pediatr Hematol Oncol; 1986; 3(2):127-34. PubMed ID: 3153222
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate and 7-hydroxy-methotrexate pharmacokinetics following intravenous bolus administration and high-dose infusion of methotrexate.
Bore P; Bruno R; Lena N; Favre R; Cano JP
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1385-90. PubMed ID: 3500051
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs.
Lu GW; Jun HW; Dzimianski MT; Qiu HC; McCall JW
Pharm Res; 1995 Oct; 12(10):1474-7. PubMed ID: 8584484
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma.
Pignon T; Lacarelle B; Duffaud F; Guillet P; Catalin J; Durand A; Monjanel S; Favre R
Cancer Chemother Pharmacol; 1994; 33(5):420-4. PubMed ID: 8306417
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.
Chen ML; Chiou WL
J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate for osteosarcoma: toxicity and clinical results.
Breithaupt H; Küenzlen E
Oncology; 1983; 40(2):85-9. PubMed ID: 6600827
[TBL] [Abstract][Full Text] [Related]
11. Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.
Joerger M; Huitema AD; van den Bongard HJ; Baas P; Schornagel JH; Schellens JH; Beijnen JH
Br J Clin Pharmacol; 2006 Jul; 62(1):71-80. PubMed ID: 16842380
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
[TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
Chládková J; Hak J; Martínková J; Chládek J
Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
[TBL] [Abstract][Full Text] [Related]
14. 7-Hydroxy-methotrexate and clinical toxicity following high-dose methotrexate therapy.
Erttmann R; Bielack S; Landbeck G
J Cancer Res Clin Oncol; 1985; 109(1):86-8. PubMed ID: 3855853
[TBL] [Abstract][Full Text] [Related]
15. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.
Winograd B; Lippens RJ; Oosterbaan MJ; Dirks MJ; Vree TB; van der Kleijn E
Eur J Clin Pharmacol; 1986; 30(2):231-8. PubMed ID: 3709652
[TBL] [Abstract][Full Text] [Related]
16. [A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy].
Miyauchi Y; Mii Y; Morishita T; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Hino M; Nomura Y; Nakanishi E
Gan To Kagaku Ryoho; 1996 Apr; 23(5):595-9. PubMed ID: 8678518
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate pharmacokinetics and survival in osteosarcoma.
Aquerreta I; Aldaz A; Giráldez J; Sierrasesúmaga L
Pediatr Blood Cancer; 2004 Jan; 42(1):52-8. PubMed ID: 14752795
[TBL] [Abstract][Full Text] [Related]
18. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of high-dose methotrexate after intravenous administration in Chinese osteosarcoma patients from a single institution.
Zhang W; Zhang Q; Tian X; Zhao H; Lu W; Zhen J; Niu X
Chin Med J (Engl); 2015 Jan; 128(1):111-8. PubMed ID: 25563323
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemia.
Borsi JD; Sagen E; Romslo I; Moe PJ
Med Pediatr Oncol; 1990; 18(3):217-24. PubMed ID: 2329967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]